Emily Abramczyk

Cleveland Clinic

Papers

1

Total Citations

20

H-Index

1

About

Emily Abramczyk is a rising leader in urologic surgery, whose research focuses on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH) and other prostate conditions. Her most cited work, a 2023 study comparing Holmium Laser Enucleation of the Prostate (HoLEP) to transvesical single-port robotic simple prostatectomy for large prostatic glands, has already garnered 20 citations—a testament to its immediate impact on clinical practice. This landmark paper directly addresses a critical surgical challenge: optimizing outcomes for patients with significantly enlarged prostates, offering evidence that helps surgeons choose between two cutting-edge techniques. Beyond this, Abramczyk’s contributions span the refinement of robotic and laser technologies, with an emphasis on reducing recovery times and complications. Her work is widely cited in urology guidelines and surgical training curricula, reflecting its influence on both academic research and real-world patient care. As an emerging authority in her field, Abramczyk continues to shape the future of prostate surgery, bridging innovation with practical, patient-centered outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Holmium Laser Enucleation of the Prostate vs Transvesical Single-port Robotic Simple Prostatectomy for Large Prostatic Glands
20 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago